Evolus Inc. EOLS
$6.76
▲ +3.38% 24H
About
Evolus is a performance beauty company specializing in injectable aesthetic products within the global cash-pay aesthetics market across the United States, Canada, Europe, and Australia. The company's flagship product, Jeuveau, is a proprietary botulinum toxin formulation designed to temporarily improve the appearance …
SectorHealthcare
ExchangeNASDAQ
IndustryDrug Manufacturers - Specialty & Generic
CountryUnited States
Employees350
TickerEOLS
Statistics
Market Cap$445.4M
Revenue (TTM)$297.2M
Net Income-$51.6M
Net Margin-17.4%
EPS$-0.80
P/E-8.13
P/S1.42
P/B-14.73
EV/EBITDA-24.09
ROE223.5%
Dividend Yield—
Price$6.76
Data: Twelve Data · Revenue = mcap / P/S